1. Home
  2. OPK vs INMD Comparison

OPK vs INMD Comparison

Compare OPK & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.47

Market Cap

921.2M

Sector

Health Care

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$13.92

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPK
INMD
Founded
2006
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
921.2M
842.0M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
OPK
INMD
Price
$1.47
$13.92
Analyst Decision
Hold
Hold
Analyst Count
3
5
Target Price
$1.60
$17.33
AVG Volume (30 Days)
2.3M
919.7K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$606,879,000.00
N/A
Revenue This Year
N/A
$1.74
Revenue Next Year
$4.24
$3.26
P/E Ratio
N/A
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$12.72
52 Week High
$1.60
$16.74

Technical Indicators

Market Signals
Indicator
OPK
INMD
Relative Strength Index (RSI) 82.58 48.25
Support Level $1.25 $13.71
Resistance Level $1.52 $14.70
Average True Range (ATR) 0.06 0.28
MACD 0.03 -0.01
Stochastic Oscillator 89.41 51.49

Price Performance

Historical Comparison
OPK
INMD

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: